Publicaciones en colaboración con investigadores/as de University of Toronto (15)

2024

  1. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

2023

  1. Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis

    World Journal of Pediatrics, Vol. 19, Núm. 8, pp. 727-740

2021

  1. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study

    The Lancet Child and Adolescent Health, Vol. 5, Núm. 11, pp. 800-813

  2. Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

    Journal of Clinical Oncology, Vol. 39, Núm. 25, pp. 2779-2790

2020

  1. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas

    Cancer Cell, Vol. 37, Núm. 4, pp. 569-583.e5

2019

  1. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

    Cancer Cell, Vol. 36, Núm. 1, pp. 51-67.e7

  2. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

    Nature Communications, Vol. 10, Núm. 1

  3. Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition

    JCO Precision Oncology

  4. Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost

    Cancer, Vol. 125, Núm. 11, pp. 1867-1876

2017

  1. Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Cancer Cell, Vol. 31, Núm. 6, pp. 737-754.e6

  2. Multiplex detection of pediatric low-grade glioma signature fusion transcripts and duplications using the NanoString nCounter system

    Journal of Neuropathology and Experimental Neurology, Vol. 76, Núm. 7, pp. 562-570

  3. Pediatric low-grade gliomas: Implications of the biologic era

    Neuro-Oncology, Vol. 19, Núm. 6, pp. 750-761

2016

  1. Profound clinical and radiological response to BRAF inhibition in a 2-month-old diencephalic child with hypothalamic/chiasmatic glioma

    Pediatric Blood and Cancer, Vol. 63, Núm. 11, pp. 2038-2041

  2. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

    The Lancet Oncology, Vol. 17, Núm. 4, pp. 484-495

  3. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477